NCT04559373

Brief Summary

While stroke survivors discharged from rehabilitation present with some recovery in mobility, their ability to ambulate in the community remains limited. The investigators propose to test a novel, low-cost, intensive and individually tailored intervention that combines virtual reality (VR) and field training to enhance community ambulation and participation in stroke survivors discharged from rehabilitation. The aims are to: (1) Assess feasibility, acceptability, safety and adherence of the intervention in stroke survivors; and (2) Examine the extent to which post-intervention changes in functional walking and participation to community walking vary according to walking, cognitive and visual-perceptual abilities. The investigators will use a virtual environment prototype simulating a shopping mall and surrounding streets, in which participants will interact using VR goggles and game controllers. Scenarios of increasing levels of complexity will be introduced. This intervention study involves a single group, multiple pre- multiple post- study design where chronic stroke participants will engage in a 4-week training program. The program will include VR training sessions performed in the clinical setting (3/week) and practice of community ambulation skills while supervised by family/caregivers (2/week). Participants will be assessed on measures of functional walking, balance \& mobility and participation to community walking. Adherence, safety and acceptability will be documented. This study will generate foundation knowledge on the response to the intervention based on individual capacities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
8mo left

Started Apr 2021

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Apr 2021Dec 2026

First Submitted

Initial submission to the registry

July 6, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 22, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

5.2 years

First QC Date

July 6, 2020

Last Update Submit

February 18, 2026

Conditions

Keywords

AgingBiomechanicsCommunity ambulationInterventionLocomotionRehabilitationSensorimotor integrationVirtual reality

Outcome Measures

Primary Outcomes (2)

  • Post-intervention change in the Six Minute Walk Test (6MWT)

    The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.

    Pre-intervention (Week4) and post-intervention (Week8)

  • Change in the Six Minute Walk Test (6MWT) at Follow-up

    The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.

    Post-intervention (Week8) and Follow-up (Week12)

Secondary Outcomes (6)

  • Dynamic Gait Index

    Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  • 5m Walk Test

    Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  • Activities-Specific Balance Confidence Scale

    Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  • Trip Activity Log

    Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  • Environmental Analysis of Mobility Questionnaire

    Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  • +1 more secondary outcomes

Other Outcomes (8)

  • Adherence to intervention

    3x/week over the 4-week intervention for the virtual reality component; 2x/week over the 4-week intervention for the field training component

  • Safety of the intervention

    3x/week over the 4-week intervention of the virtual reality component

  • Acceptability of the intervention

    Post-intervention (Week8)

  • +5 more other outcomes

Study Arms (1)

Virtual Reality and Field Practice Training (VRFT)

EXPERIMENTAL

Participants will engage in a 4-week VRFT intervention that comprises of 1-hour training sessions, 3 times/week.

Other: Virtual Reality and Field Training (VRFT)

Interventions

The VRFT intervention involves the intensive practice of community ambulation skills. Some of the training sessions will be performed in a virtual environment, while others will consist of field training exercises in the community. During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc.

Virtual Reality and Field Practice Training (VRFT)

Eligibility Criteria

Age40 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • People with chronic stroke and persistent deficits in walking / visual-perceptual / cognitive capacities. They can be male or female, aged from 40 to 74 years, with normal/corrected visual and auditory acuity, and present with:
  • First-ever supratentorial unilateral stroke 9-24 months ago (such chronicity will ensure steady-state mobility without long-term disuse-related changes
  • Mild-to-moderate hemiparesis (Chedoke McMaster Stoke Assessment stages 4/7-6/7 on postural control, leg \& foot)
  • Ability to walk independently with/without walking aids for at least 1 min at 0.4-0.9 m/s (such a speed range indicates mobility not sufficient for functional community ambulation: shopping \~1.1m/s, street crossing \~1.2 m/s)
  • Intact or mildly affected cognitive function (Montreal Cognitive Assessment scores ≥ 22/30)
  • Intact to moderately affected visual-perceptual function (positive scores on a maximum of 3/6 tasks on the Behavioural Inattention Test)

You may not qualify if:

  • Subjects with comorbidities interfering with walking
  • Subjects with comorbidities interfering with visual perception
  • Subjects without medical clearance for exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Jewish Rehabilitation Hospital

Laval, Quebec, H7V1R2, Canada

RECRUITING

Institut de réadaptation en déficience physique de Québec

Québec, Quebec, G1W 1P7, Canada

NOT YET RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Anouk Lamontagne, PhD

    McGill University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anouk Lamontagne, PhD

CONTACT

Andréanne Blanchette, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Intervention study involving a single group, multiple-pre, multiple-post, sequential design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 6, 2020

First Posted

September 22, 2020

Study Start

April 1, 2021

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 20, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome measure will be made available.

Time Frame
Data will be available within 6 months of study completion
Access Criteria
De-identified data will be deposited in a REDCap database and made available to collaborators. Data may also be made available to other researchers via an institutional data repository that will allow adhering to FAIR principles.

Locations